FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2025
Back to search
Official data from USPTO
ALGENSCRIBE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALGENSCRIBE
ST13
US500000079374320Class
1, 5, 42, 44
Filing
79374320
Registration
7424131
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
04/07/2023
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
FLEMING, STEPHANIE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ALGENSCRIBE
Representatives
Cathleen E. Stadecker Downs Rachlin Martin PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiotechnological products intended for use in industryscienceagriculturehorticulturechemical and biochemical preparations for scientific purposeschemicals for use in biotechnological product developmentchemicals and biochemicals used in industry; Chemicalbiochemicalbiotechnological and bacteriological products for use in research and testing laboratorieschemical and biochemical preparations for research purposeschemicals for use in biotechnological product developmentother than for medical or veterinary purposes; Chemical and biochemical preparations used in the manufacture of pharmaceuticals; Biotechnological products used in the manufacture of pharmaceuticalschemicals for use in biotechnological product development; Chemical preparations used for the production of gene and cell therapies; Diagnostic preparations other than for medical use; Diagnostic reagents and preparations for scientific use; Diagnostic reagents and preparations for scientific laboratories; Reagents for analytical usechemical analysis reagents other than for medical or veterinary purposes; Reagents for the extractionpreservation and processing of humananimalplant or microbiological samples for collecting genetic or genomic information other than for medical or veterinary purposes; Diagnostic testing preparationsreagents and assays for scientific use
Class 5
Veterinary and pharmaceutical preparationsgene-based and cell-based therapeutic preparations for treating cancer; Pharmaceutical preparations for gene and cell therapy; Biological preparations for use in gene therapy and cell therapy for medical purposes; Micro-organism cultures and preparations for medicalpharmaceutical and/or veterinary use; Bacteriological preparations for medicalpharmaceutical and/or veterinary use; Diagnostic reagents and preparations for clinicalmedicalpharmaceutical and/or veterinary use; Diagnostic test preparations consisting principally of reagents and assays for clinicalmedicalpharmaceutical and/or veterinary use
Class 42
Scientific and industrial researchchemical researchresearch and development of new biological and medical products; Scientific geneticmedicalpharmaceutical and veterinary research; Scientific geneticmedicalpharmaceutical and veterinary researchresearch in the field of pharmaceutical preparations for gene and cell therapy; Research in chemistrybiologybiochemistrymolecular biology; Scientific research in the field of biologygenetics and genomics; Scientific research services using genomic analysis procedures; Biologicalscientific genetic and genomic handling and analysis services for scientific use; Structural and functional genome analysisfor scientific purposes; Biotechnological research and development for third partiesincluding scientific feasibility studies on genetic associationsgenome mappinggenome analysis and genome scanning; Scientific analysis in the field of genetics and genomics; Scientific research and development of biochemical analysisbiological analysis and molecular biology techniques; Research and development of new molecules intended for use in industrypreparing and providing biological materials and particularly stem cells; Developing pharmaceutical drugs and therapeutics; Scientific laboratory servicesbiological material modifications
Class 44
Medical diagnostic servicesincluding diagnostic and reagent sample testing services for third parties; Genetic testing for medical purposesincluding genome mappinggenome analysis and genome scanning; Biologicalgenetic and genomic handling and analysis services for medical use; Medical genetic or genomic testing for detecting risksdiagnosing illness or selecting treatment in humansanimals or plants
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/21/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/13/2025
FIMP
FINAL DISPOSITION PROCESSED
02/13/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/24/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/24/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2024
RFNT
REFUSAL PROCESSED BY IB
02/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/29/2024
RFRR
REFUSAL PROCESSED BY MPU
01/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/12/2024
CNRT
NON-FINAL ACTION WRITTEN
01/11/2024
DOCK
ASSIGNED TO EXAMINER
01/04/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/13/2023
Continuous trademark protection
Get notified about every new filing that threatens ALGENSCRIBE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.